NEXS BioMedica Corporation

NEXS BIOMEDICA CORPORATION, a leading innovator in biotechnology and pharmaceutical development, today announced a groundbreaking strategic partnership with Microsoft.

NEXS Technology Group is excited to announce its acceptance into the prestigious AWS Startup Program, a significant milestone that will propel the development and deployment of CancerScope-AI, our state-of-the-art artificial intelligence tool.

NEXS BioMedica, a forward-thinking biotech pharmaceutical company, proudly introduces CancerScope-AI, an innovative artificial intelligence system set to transform the battle against rare cancers.

NEXS BioMedica Corporation, a leader in pharmaceutical innovation, is calling for urgent reforms to accelerate the development and approval of drugs targeting obesity, a chronic illness affecting over 40% of U.S. adults.